7.0) was inoculated with 20 ml of seed culture prepared above and incubated at 28°C, 160 rpm, and 85% humidity for 192 hours (8 days). The fermentation was harvested by centrifugation ( 4,500 rpm, 15 minutes, 4°C) and the supernatant (2200 ml) was decanted and stored at 4°C until used. The pellet was extracted with I 000 ml of 90% aqueous acetone for 2 hours and the extr~ct was separated from the cell debris by centrifugation ( 4,500 rpm, 15 minutes, 4°C) and concentrated in vacuo (30 mbar, 30°C).
The remaining aqueous suspension (200 ml) was also stored at 4°C until used.
The production of the bioactive components and their purification was monitored by inhibitory activity against Candida albicans in a cut-well agar diffusion assay. The fcnnentation supernatant and the concentrated pellet extract were recombined and adsorbed onto a column (2.5 em i.d.X 22 em L, 110 ml) packed with D iaion® HP20 (Mitsubishi Kasei) that had been equilibrated in water (1 000 ml). The column was sequentially eluted at 5 ml/minute with water (600 ml), a gradient of 0 to 20% acetone (350 ml), 20% acetone (350 ml), a gradient of 20 to 100% acetone (550 ml) and I 00% acetone (550 ml), collecting fractions at 5-minute intervals. The active eluates (60-80% acetone) were combined and concentrated in vacuo (<30°C), and the residual aqueous solution was lyophi lized to yield 1.8 g of crude material. The sample was dissolved in a mixture of 1.25 ml of buffer A (0. 1 M NH 4 0Ac, pH 4.9) and 3.75 ml of methanol, and was top-loaded on a column (2.2 cmX35 em, ] 35 ml) packed with cl8 silica gel (Amicon) that had been pre-equilibrated with 75% methanol in 0.1 M NH 4 0Ac (pH 4.9). The column was eluted at 5 ml/minute with the same solvent mixture. The active fractions were each analyzed by HPLC (Amicon C 18 , 4.6mmX100mm, l.7ml; 75% methanol in 0.1 M NH 4 0Ac, pH 4.9) and the fractions corresponding to separate peaks (as detected by UV) combined accordingly. These pooled active fractions were further purified by reverse-phase HPLC on a Matrex C 18 column (MODcoJ®, 2.12cmX25cm, 90ml) eluted with 75% methanol in 0.1 M NH 4 0Ac pH 4.9, to obtain MF-EA 705a (2, 65 mg), MF-EA-705j3 (3, 20 mg) and actina pyrone A (1, 12 mg). The physico-chemical properties of compounds 2 and 3 are summarized in Table 1. MF-EA-705a (2) (Table 2) and the NOESY data (Figure 2b ). The configuration of the C7-C8 olefin was assigned as shown based on a NOESY correlation between H-7 and H-20. The placement of the C 20 methyl group at C-8 was assigned on the basis of COSY and HMBC data. Further HMBC correlations from H-3 to C-1 and C-5, and from H-2 to C-4 established the terminal carboxylic acid portion of the chain. The remaining portion of the molecule, C-15 to C-18, was determined similarly. C NMR (100MHz) data ofMF-EA-705a (3). 
* not observed
The C-19 methyl group was placed at C-12 on the basis of HMBC correlations between CH 3 -19 to C-11 and C-13.
MF-EA-705{3 (3) was isolated as an optically-inactive colorless oil. Its molecular formula, C 20 H 24 0 2 , was 2 amu heavier than that of MF-EA-705a (2) . Analysis of the NMR data (Table 3) The purified compounds MF-EA-705a (2) and MF-EA 705{3 (3) were inactive at a concentration of 128 )lg/ml against Candida albicans, C. glabrata, C. krusei, Cryptococcus neoformans, and Aspe1gillus fumigatus. The minimum inhibitory concentration (MIC) of (2) 4, 21.8, 14.4 127.3, 134.4, 14.4 134.4, 21.8 130.0, 136.0 127.6, 140.4, 138.3 unsuitability of this compound as a drug candidate. The activity observed and followed during bioassay-guided fractionation was thus due to high concentrations of the compound being assayed in the cut-well agar plates.
Nevertheless, these compounds are interesting novel metabolites, with a similar compound having been isolated only once previously in the microbial natural product literature. 21
